Kingsley I. Ndoh
Kingsley Ndoh is a global health leader and MedTech entrepreneur with more than a decade of experience leading innovative global health programs to improve equitable access to cancer care around the world.
ENTREPRENEUR. INNOVATOR. GLOBAL HEALTH LEADER.
Kingsley I. Ndoh is the Founder & CEO of Hurone AI, a MedTech startup headquartered in Seattle, Washington, which is accelerating global access to precision cancer care and transforming global oncology through the power of artificial intelligence.
Dr. Ndoh received his medical degree from the University of Jos, and an MPH in Global Health from the University of Washington (UW). He led the first ever access agreement for affordable cancer medicines between the Nigerian government and leading pharmaceutical companies in his role at BIO Ventures for Global Health.
He is a Clinical Assistant Professor at the UW Department of Global Health and an Affiliate Member of the Vaccines and Infectious Disease Division at the Fred Hutchinson Cancer Center.
Kingsley is also a Working Group Member of the U.S. President’s Cancer Panel on Technologies for Cancer Navigation. He served as a former member of the World Health Organization’s Global Breast Cancer Initiative Technical Working Committee and a UICC Young Leader alumnus. Most recently, he was awarded the Washington Global Health Alliance Rising Star Award.
HURONE AI
I’m currently building Hurone AI, a MedTech startup headquartered in Seattle, Washington.
The vision for Hurone AI was born after my aunt died of colorectal cancer in Nigeria. Her diagnosis, treatment and death opened my eyes to the gaps in cancer care that are the unfortunate reality for people in underrepresented populations around the world.
To solve this problem, Hurone AI is accelerating global access to precision cancer care and transforming global oncology through the power of artificial intelligence.
We empower oncologists in care delivery to improve patient outcomes, and provide pharma companies and CROs with real-world data and AI solutions to support clinical trials in order to make cancer care accessible to everyone, everywhere.
I’m uniquely passionate about this vision because of my aunt, and because I believe in the power of artificial intelligence to improve health outcomes around the world. My team and I are working tirelessly to make health equity in cancer care a tangible reality.